Manufacturer
Novo Nordisk NDC Codes
Finished products listed with the FDA under labeler names that contain “Novo Nordisk”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Rybelsusoral semaglutide | Semaglutide 14 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4314 |
| Saxendaliraglutide | Liraglutide 6 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-2800 |
| Sogroyasomapacitan-beco | Somapacitan 6.7 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-2030 |
| Sogroyasomapacitan-beco | Somapacitan 3.3 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-2035 |
| Sogroyasomapacitan-beco | Somapacitan 10 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-2037 |
| Tresibainsulin degludec | Insulin degludec 200 U/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-2550 |
| Tresibainsulin degludec | Insulin degludec 100 U/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-2660 |
| Tresibainsulin degludec | Insulin degludec 100 U/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-2662 |
| Trettencoagulation factor xiii a-subunit (recombinant) | — | Kit | Novo Nordisk | 0169-7013 |
| Vagifemestradiol | Estradiol 10 ug/1 | InsertVaginal | Novo Nordisk | 0169-5176 |
| Victozaliraglutide | Liraglutide 6 mg/mL | InjectionSubcutaneous | Novo Nordisk | 0169-4060 |
| Wegovysemaglutide | Semaglutide 4 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4404 |
| Wegovysemaglutide | Semaglutide 9 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4409 |
| Wegovysemaglutide | Semaglutide 1.5 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4415 |
| Wegovysemaglutide | Semaglutide 25 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4425 |
| Wegovysemaglutide | Semaglutide 1 mg/.5mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4501 |
| Wegovysemaglutide | Semaglutide .5 mg/.5mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4505 |
| Wegovysemaglutide | Semaglutide 1.7 mg/.75mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4517 |
| Wegovysemaglutide | Semaglutide 2.4 mg/.75mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4524 |
| Wegovysemaglutide | Semaglutide .25 mg/.5mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4525 |
| Wegovysemaglutide | Semaglutide 7.2 mg/.75mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4572 |
| Wegovysemaglutide | Semaglutide 3.2 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4915 |
| Xultophy 100/3.6insulin degludec and liraglutide | Insulin degludec 100 [iU]/mL; Liraglutide 3.6 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-2911 |
| Zegaloguedasiglucagon | Dasiglucagon .6 mg/.6mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-1912 |
| Zegaloguedasiglucagon | Dasiglucagon .6 mg/.6mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-1913 |